Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
J Cosmet Sci ; 71(6): 385-397, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33413783

RESUMO

Chemical peeling can reduce skin hyperpigmentation; however, once exhausted its thinning action, the depigmentation process does not continue further. We carried out a monocentric, prospective, noncontrolled study aimed at the evaluation of the efficacy, safety, ease of use, pleasantness, and tolerability of a depigmentation topical treatment program in women submitted to a previous chemical peeling. The topical treatment has been administered daily for 30 days to 16 women submitted to a chemical peeling containing a fixed-dose combination of salicylic acid, pyruvic acid, and retinoic acid within 7 days before study inclusion. Target skin areas have been evaluated for melanin concentration and skin texture before peeling and at study visits 1 (after peeling) and 2 (after the 30-day treatment). The topical treatment program induced a decrease in melanin concentration between study visits 1 and 2 (-4.74%; p = 0.0008). It reduced melanin concentration even further between the prepeeling period and visit 2 (-7.8%; p < 0.0001). Patients rated the depigmentation topical treatment program as "very simple" (87.5%) and "simple" (12.5%) to use and as "pleasant" (56.25%) and "very pleasant" (43.75%). Results support the use of the home-based depigmentation topical treatment program to potentiate the effectiveness of a previous chemical peeling in hyperpigmentation reduction.


Assuntos
Abrasão Química , Hiperpigmentação , Preparações Clareadoras de Pele , Face , Feminino , Humanos , Hiperpigmentação/tratamento farmacológico , Estudos Prospectivos , Pele/efeitos dos fármacos
2.
Food Funct ; 9(7): 3845-3852, 2018 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-29951651

RESUMO

Background - The clinical hypocholesterolemic effect of nutraceutical compounds (NCs) containing red yeast rice extracts providing a daily dose of 2.5-10 mg of monacolin K is now well established. For this reason, NCs may be a viable alternative to the statin drugs commonly used to lower cholesterol levels. However, in order to avoid some possible statin-like side effects, most NCs available on the market contain low doses of monacolin K, which could reduce their efficacy. The aim of this study was to investigate the efficacy and safety of a NC containing high doses of monacolin K (10 mg) in improving the lipid profile and glucose metabolism when added to the diet versus the diet alone in a group of hypertensive and hyper-cholesterolemic subjects at low cardiovascular risk. Methods - Thirty subjects with grade-1 essential hypertension (mean age 51.5 ± 7.8 years, 62.9% males) were enrolled in the treatment group (NC group). These subjects followed a programmed diet and took one tablet a day of a NC containing red yeast rice, policosanols, resveratrol and chromium picolinate for 1 month and were compared with an equivalent group of subjects that followed only a diet program. Differences in serum total cholesterol (TC), low-density- and high-density-lipoprotein cholesterol (LDLC and HDLC), triglycerides (TG) and blood glucose between groups were compared by analysis of variance. Results - In both groups, a significant reduction of TC, TG and LDLC was observed. In the treatment group from the baseline to the follow-up the reduction of TC (230.93 ± 28.0 vs. 188.63 ± 18.1, p < 0.001) and LDLC (153.10 ± 22.5 vs. 116.54 ± 17.7, p < 0.001) was significantly greater compared to the control group (differences between treatments = 9.19% and 12.29%, respectively); in addition a significant higher reduction in blood glucose (89.1 ± 7.6 vs. 83.7 ± 4.6, p < 0.001) was also observed (differences between treatments = 4.28%). HDLC levels remained unchanged in both groups. Conclusions - In summary, the NC containing high doses of monacolin K appeared to be safe, well tolerated and effective at improving lipid and glucose patterns.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Hipercolesterolemia/tratamento farmacológico , Hipertensão/tratamento farmacológico , Lipídeos/sangue , Lovastatina/administração & dosagem , Adulto , Produtos Biológicos/química , Glicemia/metabolismo , Doenças Cardiovasculares/metabolismo , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Suplementos Nutricionais/análise , Feminino , Humanos , Hipercolesterolemia/metabolismo , Hipertensão/metabolismo , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Fatores de Tempo , Triglicerídeos/sangue
3.
Int J Environ Health Res ; 25(4): 393-404, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25245102

RESUMO

Leukaemia risk in adult populations exposed to environmental air pollution is poorly investigated. We have carried out a population-based case-control study in an area that included a fossil fuel power plant, a coke oven and two big chemical industries. Information on residential history and several risk factors for leukaemia was obtained from 164 cases, diagnosed between 2002 and 2005, and 279 controls. A higher risk for subjects residing in polluted areas was observed, but statistical significance was not reached (adjusted OR = 1.11 and 1.56 for subjects living in moderately and in heavily polluted zones, respectively, p = 0.190). Results suggest a possible aetiological role of residential air pollution from industrial sites on the risk of developing leukaemia in adult populations. However, the proportion of eligible subjects excluded from the study and the lack of any measure of air pollution prevent definitive conclusions from being drawn.


Assuntos
Poluentes Atmosféricos/toxicidade , Exposição Ambiental , Leucemia/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Indústria Química , Feminino , Humanos , Itália/epidemiologia , Leucemia/induzido quimicamente , Masculino , Pessoa de Meia-Idade , Centrais Elétricas , Fatores de Risco , Adulto Jovem
4.
Homeopathy ; 102(4): 254-61, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24050771

RESUMO

PURPOSE: The primary objective of this open-label, retrospective, observational study was to examine change in indicators of anxiety changed after treatment period of at least 1 month with the homeopathic-complex medicine Datif-PC(®). A secondary objective was to describe the quantitative changes in the sleep pattern of the subjects included in the study. METHODS: The study population consisted of 71 subjects suffering from mild to moderate anxiety, who were treated with a homeopathic-complex medicine. The subjects had attended at least 2 consultations during the year 2010, with the second visit taking place at least 30 days after the first baseline visit. At both visits, subjects were administered the State-Trait Anxiety Inventory (STAI)-Y questionnaire (consisting of trait and state subscales) to assess their level of anxiety. Sleep quality was assessed based on the subjects' self-reported number of hours slept and number of night-time awakenings, before and after treatment. RESULTS: Compared to baseline, the average (STAI)-state score at visit 2 decreased by more than 6 points, while the STAI-trait score decreased by more than 3 points. This was statistically significant (p < 0.0001) for both subscales. These findings were stable in subgroup analyses (gender, age and anxiety level). The average number of hours slept per night increased significantly at visit 2 compared to baseline (from 5.1 ± 1.1 to 5.56 ± 0.9 h, p < 0.0001). A marked decrease in the average number of night-time awakenings was also observed at the second visit (-42%, p < 0.0001). CONCLUSIONS: This retrospective observational study suggests that treatment of anxiety and sleep disorders with Datif-PC(®) can produce notable improvements even in a short period of time. Furthermore, the observed effects were not affected by sex, age or baseline anxiety. Further controlled, randomized studies are justified.


Assuntos
Ansiedade/tratamento farmacológico , Homeopatia/métodos , Preparações de Plantas/uso terapêutico , Transtornos do Sono-Vigília/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Ansiedade/complicações , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fitoterapia , Estudos Retrospectivos , Transtornos do Sono-Vigília/complicações
5.
Homeopathy ; 101(4): 211-6, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23089216

RESUMO

OBJECTIVE: To assess the effect of Symphytum 5CH on the postoperative pain and swelling after placement of a titanium dental implant. MATERIAL AND METHODS: Data on pain and swelling following pure titanium implants were reviewed. Patients were treated postoperatively with ketoprofen only or ketoprofen and Symphytum 5CH, according to the treating dentist's usual practice. Demographics and baseline characteristics were recorded and compared. Pain and swelling were compared between the two treatment groups using the Wilcoxon rank sum test and ordinal logistic regression, estimating odds ratios and confidence intervals. RESULTS: 100 implants in 57 patients (28 males, 29 females) were treated with ketoprofen alone; 100 implants in 60 patients (14 males, 46 females) with ketoprofen and Symphytum. The group treated with ketoprofen and Symphytum appeared to have a better response in terms of both pain and swelling. Ordinal logistic regression: pain 0.23, 95% CI 0.13-0.41; swelling 0.24, 95% CI 0.13-0.44. Correction for demographics and implant characteristics greatly widened the confidence intervals so that the results were no longer statistically significant (pain: OR = 0.15, 95% CI 0.07-34.56; swelling OR = 0.18, 95% CI 0.07-46.78). CONCLUSIONS: Adding Symphytum 5CH to conventional analgesia may reduce pain and swelling after minor dental implant surgery. No firm conclusion can be drawn since the results are confounded by baseline differences, principally gender. Further, randomized, studies should be conducted.


Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Implantes Dentários/efeitos adversos , Edema/tratamento farmacológico , Dor Facial/tratamento farmacológico , Homeopatia/métodos , Cetoprofeno/administração & dosagem , Adulto , Idoso , Confrei , Intervalos de Confiança , Quimioterapia Combinada , Edema/etiologia , Dor Facial/etiologia , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Medição da Dor , Dor Pós-Operatória/tratamento farmacológico , Extratos Vegetais/administração & dosagem , Resultado do Tratamento
6.
Vaccine ; 30(27): 4086-94, 2012 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-22521851

RESUMO

Protective antibody responses to a single dose of 2009 pandemic vaccines have been observed in the majority of healthy subjects aged more than 3 years. These findings suggest that immune memory lymphocytes primed by previous exposure to seasonal influenza antigens are recruited in the response to A/H1N1 pandemic vaccines and allow rapid seroconversion. However, a clear dissection of the immune memory components favoring a fast response to pandemic vaccination is still lacking. Here we report the results from a clinical study where antibody, CD4+ T cell, plasmablast and memory B cell responses to one dose of an MF59-adjuvanted A/H1N1 pandemic vaccine were analyzed in healthy adults. While confirming the rapid appearance of antibodies neutralizing the A/H1N1 pandemic virus, we show here that the response is dominated by IgG-switched antibodies already in the first week after vaccination. In addition, we found that vaccination induces the rapid expansion of pre-existing CD4+ T cells and IgG-memory B lymphocytes cross-reactive to seasonal and pandemic A/H1N1 antigens. These data shed light on the different components of the immune response to the 2009 H1N1 pandemic influenza vaccination and may have implications in the design of vaccination strategies against future influenza pandemics.


Assuntos
Adjuvantes Imunológicos/administração & dosagem , Anticorpos Neutralizantes/sangue , Anticorpos Antivirais/sangue , Memória Imunológica , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza/imunologia , Polissorbatos/administração & dosagem , Esqualeno/administração & dosagem , Adolescente , Adulto , Linfócitos B/imunologia , Linfócitos T CD4-Positivos/imunologia , Reações Cruzadas , Feminino , Humanos , Vacinas contra Influenza/administração & dosagem , Masculino , Pessoa de Meia-Idade , Vacinação/métodos , Adulto Jovem
7.
Clin Lab ; 57(11-12): 909-18, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22239021

RESUMO

BACKGROUND: As the accuracy of the "Sugar Test" is currently debated, this study was conducted to focus on how urine volumes may impact the test results. METHODS: Fifty-five subjects, 23 healthy and 32 with Irritable Bowel Syndrome (IBS), were enrolled. Lactulose and D-mannitol dissolved in water were administered to all the participating subjects; the urine excreted was collected and the total urine volume was measured. The urine samples were analyzed by High Performance Liquid Chromatography (HPLC). The results were expressed as percentage of urine recovery of lactulose and D-mannitol and lactulose/D-mannitol ratio (LMR). RESULTS: All subjects were divided into two groups: subjects with urine volume < 500 mL and subjects with urine volume > or = 500 mL. Urine analysis showed that the mean LMR was significantly lower in subjects with urine volume > or = 500 mL than in subjects with urine volume < 500 mL (0.02 +/- 0.02 vs 0.04 +/- 0.04; p < 0.05). A significant increase in D-mannitol recovery was found to be associated with greater urine volumes (p < 0.001). CONCLUSIONS: The urine volume may influence urinary excretion of sugar probes. Intake of liquids should therefore be carefully monitored before and during the test and the volume of urine produced over the period of collection should be precisely measured.


Assuntos
Diurese , Absorção Intestinal , Síndrome do Intestino Irritável/fisiopatologia , Lactulose , Manitol , Adulto , Cromatografia Líquida de Alta Pressão , Fatores de Confusão Epidemiológicos , Difusão , Feminino , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/ultraestrutura , Síndrome do Intestino Irritável/urina , Lactulose/farmacocinética , Lactulose/urina , Masculino , Manitol/farmacocinética , Manitol/urina , Microvilosidades/metabolismo , Pessoa de Meia-Idade , Peso Molecular , Permeabilidade
8.
Int J Cancer ; 124(1): 201-7, 2009 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-18792097

RESUMO

A median survival time of about 9 months is generally reported among malignant pleural mesothelioma cases. Recently, better results in terms of survival and performance status have been reported in clinical trials that included highly selected patients. We describe the survival of pleural mesothelioma patients and the factors predictive of survival in an unselected, population-based setting. Pleural mesothelioma cases (4,100) registered from 1990 to 2001 by 9 Italian regional mesothelioma registries contributing to the network of the National Mesothelioma Registry were followed until December 31, 2005. Univariate (Kaplan-Meier) and multivariate (Cox proportional hazards regression) analyses of survival were carried out according to selected individual characteristics, including limited information on treatment in a subset of 578 cases. The median survival time was 9.8 months (95% confidence interval: 9.4-10.1). In multivariate analysis, younger age at diagnosis and epithelioid histotype were associated with significantly reduced hazard ratios. Positive effects of gender (women) and being diagnosed in a hospital with a thoracic surgery unit were of border-line statistical significance. No association with calendar period of diagnosis or asbestos exposure was present. Treatment was not associated with a statistically significant improvement in survival. This is the largest population-based study on survival in patients with pleural mesothelioma to date. Age and morphology were the main prognostic factors. Results regarding the effect of treatment were disappointing but may be useful to assess the future impact, at the population level, of recently introduced therapies.


Assuntos
Mesotelioma/mortalidade , Neoplasias Pleurais/mortalidade , Idoso , Feminino , Humanos , Itália , Masculino , Mesotelioma/terapia , Pessoa de Meia-Idade , Análise Multivariada , Neoplasias Pleurais/terapia , Prognóstico , Modelos de Riscos Proporcionais , Sistema de Registros , Resultado do Tratamento
9.
Int J Cancer ; 124(1): 194-200, 2009 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-18792099

RESUMO

In some population-based studies, a shorter median survival was observed in peritoneal as compared with pleural, malignant mesothelioma, but in others, longer median survival times or higher proportions of long-term survivors were reported. Statistical instability could have caused these differences. We analyzed survival in peritoneal mesothelioma in a large and unselected population-based case series. Cases (338) registered from 1990 to 2001 by 9 Italian regional mesothelioma registries contributing to the network of the National Mesothelioma Registry were followed until December 31, 2005. Univariate (Kaplan-Meier) and multivariate (Cox proportional hazards regression) analyses of survival were performed according to selected individual characteristics, including limited treatment information in a subset of 194 cases. The results were compared with those obtained in a parallel study on pleural mesothelioma cases. Epithelioid histotype, younger age at diagnosis and, to a lesser degree, gender (women), and being diagnosed in a hospital with a thoracic surgery unit positively and significantly affected survival. The effect of treatment was positive but not statistically significant. No trend in the risk of death according to calendar period of diagnosis was present. Peritoneal mesothelioma cases had shorter median survival time than pleural cases, but a larger proportion of long-term survivors. Survival patterns after peritoneal and pleural mesothelioma differed markedly. Treatment was not associated with a statistically significant improvement in survival, but our study included cases first diagnosed before the introduction of the most recent therapeutic approaches. This provides a large historical comparison for future studies on survival trends at the population level.


Assuntos
Mesotelioma/mortalidade , Neoplasias Peritoneais/mortalidade , Idoso , Feminino , Humanos , Itália , Masculino , Mesotelioma/terapia , Pessoa de Meia-Idade , Análise Multivariada , Neoplasias Peritoneais/terapia , Prognóstico , Modelos de Riscos Proporcionais , Sistema de Registros , Resultado do Tratamento
12.
BMC Public Health ; 8: 21, 2008 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-18211695

RESUMO

BACKGROUND: The production of vinyl chloride (VC) and polyvinyl chloride (PVC) involves the use of various chemicals, some known to be toxic and potentially or definitely carcinogenic. The related potential risk often has not been properly investigated. Updated cancer mortality among different subgroups of workers employed in a VC-PVC production plant located in Porto Marghera (Italy) was re-analyzed using an internal reference group of workers with low (or null) exposure to VC. METHODS: Mortality of 1658 male workers was analyzed by Poisson regression. Relative risks (RRs) and 95% confidence intervals (CIs) for blue collar workers and their specific subgroups of PVC baggers, PVC compound, autoclave and other blue collar workers were calculated using technicians and clerks as an internal reference group. The follow-up covered the period 1972-1999. RESULTS: Significantly increased mortality rates were observed for all causes of death among the whole blue collar workforce (RR = 1.55; 95% CI = 1.03-2.35; 229 deaths), PVC baggers (1.72; 95% CI = 1.04-2.83; 49 deaths) and PVC compound workers (1.71; 95% CI = 1.09-2.67; 72 deaths). Liver cancer, including angiosarcoma, was increased among autoclave workers (9.57; 95% CI = 3.71-24.68; 7 deaths) and cardiovascular diseases among PVC baggers (2.25; 95% CI = 1.08-4.70; 12 deaths). Hemolymphopoietic system tumors, leukemias and lymphomas prevalently, were found only among exposed workers, with 4, 4 and 6 deaths observed among PVC baggers, PVC compound and other blue collar workers, respectively. An excess of lung cancer was found among PVC baggers. CONCLUSION: This cohort analysis, based on internal comparison, confirmed previously reported specific risk excesses for liver tumors and liver cirrhosis among autoclave workers and for lung cancer among PVC baggers, and revealed PVC compound workers as a possible new at risk group for all causes, all tumors and for liver and lung tumors. In conclusion, RRs for all causes of death and all tumors were increased among all blue collar workers.


Assuntos
Indústria Química , Doenças Profissionais/mortalidade , Cloreto de Polivinila/efeitos adversos , Cloreto de Vinil/efeitos adversos , Adulto , Causas de Morte , Estudos de Coortes , Humanos , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/induzido quimicamente , Distribuição de Poisson , Análise de Regressão
13.
Eur J Cancer ; 43(18): 2722-8, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17980576

RESUMO

Italy was an important producer of raw asbestos until 1992 (when it was banned) and it is now experiencing severe public health consequences due to large-scale industrial use of asbestos in shipbuilding and repair, asbestos-cement production, railways, buildings, chemicals and many other industrial sectors. Latency of malignant mesothelioma generally shows a large variability and the relationship with the modality of asbestos exposure is still not fully clarified. We present an analysis of latency period among the case list collected by the Italian mesothelioma register (ReNaM) in the period of diagnosis 1993-2001 (2544 malignant mesothelioma (MM) cases with asbestos exposure history). Exposure is assessed retrospectively by interview. Statistical univariate analyses were performed to estimate median and variability measures of latency time by anatomical site, gender and diagnosis period. The role of diagnostic confidence level, the morphology of the tumour and the modalities of asbestos exposure were verified in a regression multivariate model. We found a median latency period of 44.6 years increasing in recent years with a linear trend. Anatomical site, gender and morphology were not relevant for MM latency time whereas a shorter latency period was documented among occupationally exposed subjects (43 years) with respect to environmentally and household exposed ones (48 years).


Assuntos
Amianto/toxicidade , Exposição Ambiental/efeitos adversos , Neoplasias Cardíacas/epidemiologia , Mesotelioma/epidemiologia , Neoplasias Peritoneais/epidemiologia , Neoplasias Pleurais/epidemiologia , Neoplasias Testiculares/epidemiologia , Adulto , Idoso , Métodos Epidemiológicos , Feminino , Humanos , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Pericárdio , Fatores de Tempo
14.
J Public Health (Oxf) ; 28(3): 274-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16849689

RESUMO

OBJECTIVE: For registries that routinely delay case registration, the flow method does not accurately describe their completeness over time. A modification to allow for such a delay is proposed and tested. METHODS: Using original data set from Ticino Cancer Registry, Switzerland, a new data set (the delayed data set) was created by adding two years to the date of registration for each case in the original data set, to emulate the situation in a registry where registration is delayed by two years. Both the original and modified methods were then applied to both the original and the delayed data set. RESULTS: When applied to the delayed data, the original method produced estimates of completeness of 32 and 43% at one and two years after diagnosis. When the modified method was applied to the delayed data, the completeness at one and two years was correctly estimated at 0%. After the initial two-year time lag, completeness was consistently estimated by both methods. When applied to the original data, the modified method produced the same results as the original method. CONCLUSIONS: The proposed modification allows the method to be applied even when registration is delayed long after diagnosis-thus extending the range of registries for which the flow method can be used.


Assuntos
Métodos Epidemiológicos , Neoplasias/epidemiologia , Controle de Qualidade , Sistema de Registros , Bases de Dados como Assunto , Humanos , Suíça/epidemiologia , Fatores de Tempo
15.
Eur J Cancer Prev ; 15(2): 178-86, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16523016

RESUMO

Data collected by the Swiss Cancer Registries Network (ASRT/VSKR) have been used to analyse trends in thyroid cancer during the last available 20 years, to make within-country geographical comparisons for current incidence rates. Age-standardized (European population) incidence rates per 100,000 for all morphologies combined ranges from 1.62 to 2.99 among males and from 2.13 to 8.09 among females in Switzerland. Regression analyses for both sexes combined detected an increase in time for papillary cases and a decrease for other types. Age-period-cohort analyses revealed that the youngest cohorts of men and women born after 1940 had an increased risk of all types of thyroid cancer while the cohort of people born between 1920 and 1939 were at increased risk of the papillary subtype. Assuming a higher sensitivity to ionizing radiation among the youngest people, a Chernobyl effect cannot be definitively excluded and continuous study of this topic should be encouraged.


Assuntos
Adenocarcinoma/epidemiologia , Carcinoma Papilar, Variante Folicular/epidemiologia , Carcinoma Papilar/epidemiologia , Neoplasias Induzidas por Radiação/epidemiologia , Neoplasias da Glândula Tireoide/epidemiologia , Adenocarcinoma/etiologia , Adulto , Fatores Etários , Idoso , Carcinoma Papilar/etiologia , Carcinoma Papilar, Variante Folicular/etiologia , Estudos de Coortes , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Centrais Elétricas , Cinza Radioativa , Liberação Nociva de Radioativos , Sistema de Registros , Suíça/epidemiologia , Neoplasias da Glândula Tireoide/etiologia , Fatores de Tempo , Ucrânia
17.
Int J Cancer ; 115(1): 142-7, 2005 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-15645436

RESUMO

Italy was the second main asbestos producer in Europe, after the Soviet Union, until the end of the 1980s, and raw asbestos was imported on a large scale until 1992. The Italian pattern of asbestos consumption lags on average about 10 years behind the United States, Australia, the United Kingdom and the Nordic countries. Measures to reduce exposure were introduced in the mid-1970s in some workplaces. In 1986, limitations were imposed on the use of crocidolite and in 1992 asbestos was definitively banned. We have used primary pleural cancer mortality figures (1970-1999) to predict mortality from mesothelioma among Italian men in the next 30 years by age-cohort-period models and by a model based on asbestos consumption figures. The pleural cancer/mesothelioma ratio and mesothelioma misdiagnosis in the past were taken into account in the analysis. Estimated risks of birth cohorts born after 1945 decrease less quickly in Italy than in other Western countries. The findings predict a peak with about 800 mesothelioma annual deaths in the period 2012-2024. Results estimated using age-period-cohort models were similar to those obtained from the asbestos consumption model.


Assuntos
Amianto , Mesotelioma/diagnóstico , Mesotelioma/mortalidade , Neoplasias Pleurais/diagnóstico , Neoplasias Pleurais/mortalidade , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Exposição Ocupacional , Fatores de Tempo
18.
Lung Cancer ; 45 Suppl 1: S25-7, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15261429

RESUMO

The incidence of malignant mesothelioma (MM) in Italy is increasing and is assumed to be a consequence of high levels of asbestos exposure. Establishment of the National Mesothelioma Registry (ReNaM) and the co-operation of five regional centers has allowed the estimation of the incidence of malignant mesothelioma in major parts of Italy and the definition of exposure to asbestos.


Assuntos
Amianto/efeitos adversos , Exposição Ambiental , Mesotelioma/epidemiologia , Mesotelioma/etiologia , Neoplasias Pleurais/epidemiologia , Neoplasias Pleurais/etiologia , Sistema de Registros/estatística & dados numéricos , Idoso , Humanos , Incidência , Itália/epidemiologia
19.
Arch Environ Health ; 59(4): 188-93, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16189991

RESUMO

The authors investigated the relationship between asbestos exposure and respiratory cancer mortality among maintenance workers and other blue-collar workers at an Italian oil refinery. The cohort contained 931 men, 29,511 person-years, and 489 deaths. Poisson regression analysis using white-collar workers as an internal referent group provided relative risk estimates (RRs) for main causes of death, adjusted for age, age at hiring, calendar period, length of exposure, and latency. Among maintenance workers, RRs for all tumors (RR = 1.50), digestive system cancers (RR = 1.41), lung cancers (RR = 1.53), and nonmalignant respiratory diseases (RR = 1.71) were significantly increased (p < 0.05); no significant excess was found for all causes and among maintenance (RR = 1.12) and other blue-collar workers (RR = 1.01). Results confirm the increased risk of death from respiratory diseases and cancer among maintenance workers exposed to asbestos, whereas other smoking-related diseases (circulatory system) were not statistically different among groups.


Assuntos
Amianto/intoxicação , Neoplasias/etiologia , Neoplasias/mortalidade , Exposição Ocupacional , Petróleo , Doenças Respiratórias/etiologia , Doenças Respiratórias/mortalidade , Adulto , Idoso , Estudos de Coortes , Humanos , Indústrias , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Análise de Regressão
20.
Cancer Causes Control ; 14(8): 791-803, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14674744

RESUMO

OBJECTIVE: To summarize the geographical and temporal variations in incidence of pleural mesothelioma in Europe, using the extensive data available from European general cancer registries, and consider these in light of recent trends in asbestos extraction, use and import in European countries. MATERIAL AND METHODS: The data were extracted from the European Cancer Incidence and Mortality database (EUROCIM). The inclusion criteria was acceptance in Volume VII of Cancer Incidence in Five Continents. Truncated age-standardized rates per 100,000 for the ages 40-74 were used to summarise recent geographical variations. Standardized rate ratios and 95% confidence intervals for the periods 1986-1990 and 1991-1995 were compared to assess geographical variations in risk. To investigate changes in the magnitude of most recent trends, regression models fitted to the latest available 10-year period (1988-1997) were compared with trends in the previous decade. Fitted rates in younger (40-64) and older adults (65-74) in the most recent period were also compared. RESULTS: There was a great deal of geographical variation in the risk of mesothelioma, annual rates ranging from around 8 per 100,000 in Scotland, England and The Netherlands, to lower than 1 per 100,000 in Spain (0.96), Estonia (0.85), Poland (0.85) and Yugoslavia, Vojvodina (0.56) among men. The rank of the rates for women was similar to that observed for men, although rates were considerably lower. Between 1978 and 1987, rates in men significantly increased in all countries (excepting Denmark). In the following 10 years, there was a deceleration in trend, and a significant increase was detectable only in England and France. In addition, the magnitude of recent trends in younger men was generally lower than those estimated for older men, in both national and regional cancer registry settings. CONCLUSIONS: While mesothelioma incidence rates are still rising in Europe, a deceleration has started in some countries. A decrease may begin in the next few years in certain European populations considering the deceleration of observed trends in mesothelioma and asbestos exposure, as well as the recent ban on its use.


Assuntos
Mesotelioma/epidemiologia , Neoplasias Pleurais/epidemiologia , Amianto , Exposição Ambiental/efeitos adversos , Europa (Continente)/epidemiologia , Previsões , Humanos , Incidência , Modelos Lineares , Mesotelioma/etiologia , Exposição Ocupacional/efeitos adversos , Neoplasias Pleurais/etiologia , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...